Keyphrases
Stem Cells
100%
NF-B
100%
Vascular Endothelial Growth Factor
100%
Infantile Hemangioma
100%
Hemangioma
54%
Corticosteroids
18%
Interleukin-6
18%
Angiogenic Factors
18%
Soluble Urokinase Plasminogen Activator Receptor (suPAR)
18%
Monocyte Chemoattractant protein-1 (MCP-1)
18%
Immunoblotting
9%
Quantitative PCR
9%
Protein Expression
9%
Transcription Factor
9%
Protease Inhibitors
9%
Differentially Expressed
9%
Target Gene Expression
9%
Cellular Expression
9%
Immunostaining
9%
Light Chain
9%
Angiogenic Cytokines
9%
Specific Inhibition
9%
Tissue Specimens
9%
Nuclear Factor
9%
Bortezomib
9%
Activated B Cells
9%
Tumor of Infancy
9%
Stem Cell Viability
9%
Velcade
9%
Pharmacology, Toxicology and Pharmaceutical Science
Vasculotropin A
100%
Capillary Hemangioma
100%
Hemangioma
85%
Interleukin 6
28%
Angiogenic Factor
28%
Monocyte Chemotactic Protein 1
28%
Bortezomib
28%
Urokinase Receptor
28%
Western Blot
14%
Neoplasm
14%
Cell Viability
14%
Cytokine
14%
Enzyme-Linked Immunosorbent Assay
14%
Transcription Factors
14%
Nuclear Factor
14%
Immunology and Microbiology
Stem Cell
100%
Vasculotropin A
100%
Interleukin 6
25%
Angiogenic Factor
25%
Monocyte Chemotactic Protein 1
25%
Urokinase Receptor
25%
Western Blot
12%
Quantitative Reverse Transcription Polymerase Chain Reaction
12%
Gene Expression
12%
Cell Viability
12%
Transcription Factors
12%
B Cell
12%
Cytokine
12%
Protein Expression
12%
Light Chain
12%
Infancy
12%
ELISA
12%
Immunostaining
12%
Enhancer Region
12%
Biochemistry, Genetics and Molecular Biology
Stem Cell
100%
Vascular Endothelial Growth Factor A
100%
Interleukin 6
25%
Synapsin I
25%
Urokinase Receptor
25%
Quantitative Reverse Transcription Polymerase Chain Reaction
12%
Gene Expression
12%
Protein Expression
12%
Transcription Factors
12%
RNA
12%
Infancy
12%
B Cell
12%
Cytokine
12%
Cell Viability
12%
Enhancer Region
12%
Light Chain
12%
Immunostaining
12%
Immunoblotting
12%